Organon & Co. (OGN)

USD 11.2

(3.47%)

Net Income Summary of Organon & Co.

  • Organon & Co.'s latest annual net income in 2023 was 1.02 Billion USD , up 11.56% from previous year.
  • Organon & Co.'s latest quarterly net income in 2024 Q1 was 201 Million USD , down -63.19% from previous quarter.
  • Organon & Co. reported an annual net income of 917 Million USD in 2022, down -32.12% from previous year.
  • Organon & Co. reported an annual net income of 1.35 Billion USD in 2021, down -37.45% from previous year.
  • Organon & Co. reported a quarterly net income of 195 Million USD for 2024 Q2, down -2.99% from previous quarter.
  • Organon & Co. reported a quarterly net income of 201 Million USD for 2024 Q1, down -63.19% from previous quarter.

Annual Net Income Chart of Organon & Co. (2023 - 2017)

Historical Annual Net Income of Organon & Co. (2023 - 2017)

Year Net Income Net Income Growth
2023 1.02 Billion USD 11.56%
2022 917 Million USD -32.12%
2021 1.35 Billion USD -37.45%
2020 2.16 Billion USD -32.88%
2019 3.21 Billion USD 49.47%
2018 2.15 Billion USD 19.54%
2017 1.8 Billion USD 0.0%

Peer Net Income Comparison of Organon & Co.

Name Net Income Net Income Difference
AbbVie Inc. 4.86 Billion USD 78.964%
Bristol-Myers Squibb Company 8.02 Billion USD 87.252%
Bristol-Myers Squibb Company Ce 8.02 Billion USD 87.252%
Johnson & Johnson 35.15 Billion USD 97.09%
Eli Lilly and Company 5.24 Billion USD 80.479%
Merck & Co., Inc. 365 Million USD -180.274%
Novartis AG 14.85 Billion USD 93.111%
Pfizer Inc. 2.11 Billion USD 51.723%